Virtual screening and experimental validation of a METTL3-targeting peptide with in vitro antiproliferative activity against non-small cell lung cancer cells
Ying Dai, Hanying Wu, Yahui Shen, Fan Yang, Xiaohao Liu, Ting Zhuang · 2026
Read Virtual screening and experimental validation of a METTL3-targeting peptide with in vitro antiproliferative activity against non-small cell lung cancer cells by Ying Dai, Hanying Wu, Yahui Shen, Fan Yang, Xiaohao Liu, Ting Zhuang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13410616.txt.
Description
Ying Dai and co-workers hunt in 2026 for a peptide that can break up a protein pair driving lung cancer growth. The pair, METTL3 and METTL14, tag RNA in ways that help tumors progress. Blocking their join is a possible drug strategy, though no such drug is in routine use.
Computer screening of a peptide library, followed by docking tests, produced four candidates. The lead peptide bound METTL3 most tightly in lab measures and held a fitting shape in simulations. In lung cancer cells it slowed growth while sparing normal lung cells more. Treated cells showed less of the pair's RNA tagging and lower output of a growth-linked gene. Removing METTL3 blunted the peptide's effect, supporting its aim.
Catalog record
| CREATOR | Ying Dai, Hanying Wu, Yahui Shen, Fan Yang, Xiaohao Liu, Ting Zhuang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 62 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |